Dashboard
Manage Tickers

DNLIDenali Therapeutics Inc.

Nasdaq denalitherapeutics.com


$ 20.71 $ -1.39 (-6.28 %)    

Friday, 14-Jun-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 20.73
$ 22.00
$ 20.71 x 243
$ 0.00 x 0
$ 20.45 - $ 22.00
$ 14.56 - $ 33.31
1,047,522
na
3.1B
$ 1.30
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-07-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-12-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-11-2018 03-31-2018 10-Q
26 03-19-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stericycle-marinemax-agios-pharmaceuticals-and-other-big-stocks-moving-higher-on-monday
Stericycle, MarineMax, Agios Pharmaceutica...
06/03/2024 14:39:44

denali-therapeutics-says-fda-has-selected-dnl126-for-participation-in-support-for-clinical-trials-advancing-rare-disease-therapeutics-pilot-program
Denali Therapeutics Says FDA Has Selected ...
06/03/2024 12:09:50

DNL126 is an investigational enzyme replacement therapy designed to cross the BBB for the potential treatment of MPS IIIA (Sanf...

louisiana-pacific-posts-upbeat-results-joins-cricut-elanco-animal-american-public-education-and-other-big-stocks-moving-higher-on-wednesday
Louisiana-Pacific Posts Upbeat Results, Jo...
05/08/2024 15:11:22

wedbush-maintains-outperform-on-denali-therapeutics-lowers-price-target-to-30
Wedbush Maintains Outperform on Denali The...
05/08/2024 14:20:54

Wedbush analyst Laura Chico maintains Denali Therapeutics (NASDAQ:DNLI) with a Outperform and lowers the price target from $...

stifel-maintains-hold-on-denali-therapeutics-lowers-price-target-to-22
Stifel Maintains Hold on Denali Therapeuti...
05/08/2024 13:19:11

Stifel analyst Paul Mattels maintains Denali Therapeutics (NASDAQ:DNLI) with a Hold and lowers the price target from $26 to ...

hc-wainwright--co-reiterates-buy-on-denali-therapeutics-maintains-95-price-target
HC Wainwright & Co. Reiterates Buy on Dena...
05/08/2024 13:11:18

HC Wainwright & Co. analyst Andrew Fein reiterates Denali Therapeutics (NASDAQ:DNLI) with a Buy and maintains $95 price ...

denali-therapeutics-q1-eps-068-beats-070-estimate
Denali Therapeutics Q1 EPS $(0.68) Beats $...
05/07/2024 20:50:23

Denali Therapeutics (NASDAQ:DNLI) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $...

denali-therapeutics-completes-enrollment-for-regimen-g-evaluating-eif2b-agonist-dnl343-in-phase-23-healey-als-platform-trial
Denali Therapeutics Completes Enrollment f...
05/01/2024 12:11:13

ubs-maintains-buy-on-denali-therapeutics-lowers-price-target-to-32
UBS Maintains Buy on Denali Therapeutics, ...
04/09/2024 16:05:59

UBS analyst Esther Rajavelu maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and lowers the price target from $70 to $32.

denali-therapeutics-inc-files-prospectus-related-to-offer-and-resale-from-time-to-time-of-up-to-293m-shares-by-the-selling-stockholders
Denali Therapeutics Inc Files Prospectus R...
03/22/2024 20:05:07

- SEC Filing

goldman-sachs-maintains-buy-rating-for-denali-therapeutics-heres-what-you-need-to-know
Goldman Sachs Maintains Buy Rating for Den...
02/29/2024 17:00:14

goldman-sachs-maintains-buy-on-denali-therapeutics-lowers-price-target-to-50
Goldman Sachs Maintains Buy on Denali Ther...
02/29/2024 14:57:12

Goldman Sachs analyst Salveen Richter maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and lowers the price target fro...

4-analysts-assess-denali-therapeutics-what-you-need-to-know
4 Analysts Assess Denali Therapeutics: Wha...
02/28/2024 19:00:47

hc-wainwright--co-maintains-buy-on-denali-therapeutics-lowers-price-target-to-95
HC Wainwright & Co. Maintains Buy on Denal...
02/28/2024 17:27:17

HC Wainwright & Co. analyst Andrew Fein maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and lowers the price targ...

wedbush-reiterates-outperform-on-denali-therapeutics-maintains-31-price-target
Wedbush Reiterates Outperform on Denali Th...
02/28/2024 12:50:10

Wedbush analyst Laura Chico reiterates Denali Therapeutics (NASDAQ:DNLI) with a Outperform and maintains $31 price target.

why-helix-energy-solutions-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Helix Energy Solutions Shares Are Trad...
02/27/2024 18:18:56

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

norwegian-cruise-line-posts-strong-sales-joins-hims--hers-health-sterling-infrastructure-and-other-big-stocks-moving-higher-on-tuesday
Norwegian Cruise Line Posts Strong Sales, ...
02/27/2024 15:27:54

U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday.

denali-therapeutics-q4-earnings-insights
Denali Therapeutics: Q4 Earnings Insights
02/27/2024 14:00:08

denali-therapeutics-sees-fy24-operating-expenses-less-than-or-equal-to-2023-expects-cash-runway-to-extend-into-2028
Denali Therapeutics Sees FY24 Operating Ex...
02/27/2024 13:21:20

denali-therapeutics-q4-2023-gaap-eps-086-misses-081-estimate
Denali Therapeutics Q4 2023 GAAP EPS $(0.8...
02/27/2024 13:18:43

Denali Therapeutics (NASDAQ:DNLI) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)